Single-Cell Atlas Maps How Infection Site Shapes Immune Response in Sepsis
A massive multi-omic study of 281 patients reveals that where an infection originates—lung, gut, or skin—drives distinct immune programs in sepsis.
Summary
Researchers used advanced single-cell and multi-omic profiling across 281 adult and pediatric sepsis patients to reveal that the anatomical site of infection—abdomen, lung, or skin—drives distinct immune responses. A key discovery was an NR4A2+ exhausted CD4+ T cell subset enriched across multiple sepsis sites, where loss of Nr4a2 improved survival in animal models. Adult abdominal and pulmonary sepsis featured expanded proinflammatory CD8+ T, NK, and NKT cells, while pediatric pulmonary sepsis showed a unique proliferative monocyte signature. Shared inflammatory mediators like IL-6 and EN-RAGE were identified across all sites. These findings open new doors for precision immunotherapy tailored to infection source and patient age.
Detailed Summary
Sepsis remains one of the most lethal conditions in intensive care, yet treatment remains largely one-size-fits-all. A growing body of evidence suggests that where an infection originates—abdomen, lungs, skin—profoundly shapes how the immune system responds, but the molecular details have been poorly understood until now.
This landmark study from researchers at Chongqing Medical University applied an ambitious multi-omic strategy to peripheral blood mononuclear cells and plasma from 281 adults and children with sepsis, alongside healthy controls. The toolkit included single-cell RNA sequencing, T cell receptor and B cell receptor sequencing, CITE-seq (protein-level immune phenotyping), bulk RNA sequencing, and plasma proteomics—one of the most comprehensive immune atlases of sepsis to date.
The most striking finding was the identification of an NR4A2+ central memory CD4+ T cell subset enriched in abdominal, pulmonary, and skin sepsis. This subset bore hallmarks of T cell exhaustion—a dysfunctional state where immune cells lose their ability to fight infection. Critically, genetic experiments showed that deleting Nr4a2 improved survival, while overexpressing it worsened outcomes, nominating NR4A2 as a therapeutic target. In adult abdominal and pulmonary sepsis, proinflammatory CD8+ T cells, NK cells, and NKT cells expressing CCL4, CCL3, and TNF were markedly expanded. Pediatric pulmonary sepsis, by contrast, was characterized by proliferative CD14+ monocytes—a fundamentally different cellular program than adults.
Plasma proteomics identified IL-6 and EN-RAGE as shared inflammatory mediators across anatomical sites and age groups, offering potential universal biomarkers. Findings were validated in external single-cell cohorts and 164 independent individuals.
These results argue compellingly for site-specific and age-specific immune stratification in sepsis management. However, the study is limited to peripheral blood, leaving tissue-level immunity unexplored, and causal claims about human clinical outcomes await prospective trials.
Key Findings
- NR4A2+ exhausted CD4+ T cells were enriched across abdominal, pulmonary, and skin sepsis; Nr4a2 deletion improved survival in genetic models.
- Adult abdominal and pulmonary sepsis showed expanded proinflammatory CD8+ T, NK, and NKT cells expressing CCL4, CCL3, and TNF.
- Pediatric pulmonary sepsis featured a distinct proliferative CD14+ monocyte signature absent in adults.
- Plasma proteomics identified IL-6 and EN-RAGE as shared inflammatory mediators across infection sites and age groups.
- Findings were validated across external single-cell cohorts and 164 independent individuals, strengthening clinical relevance.
Methodology
The study used single-cell transcriptomics, TCR/BCR sequencing, CITE-seq, bulk RNA-seq, and plasma proteomics on 281 adult and pediatric sepsis patients and controls. Results were validated in external single-cell cohorts and 164 additional independent individuals. Causal claims about NR4A2 were supported by genetic perturbation experiments.
Study Limitations
The study analyzed peripheral blood, not infected tissue, potentially missing local immune dynamics at infection sites. Causal survival benefits of NR4A2 targeting were shown in animal models and have not been demonstrated in human clinical trials. The observational design limits conclusions about immune causality versus correlation in human sepsis outcomes.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.